Estados Unidos · Bolsa y Finanzas · Yahoo Finance

Zealand Pharma announces positive topline results from the multiple ascending dose part of Phase 1 trial with Kv1.3 ion channel blocker ZP9830

Publicado por Yahoo Finance · Estados Unidos hace 8 h

No. 21 / 2026 Zealand Pharma announces positive topline results from the multiple ascending dose part of Phase 1 trial with Kv1.3 ion channel blocker ZP9830 ZP9830 is a novel…

Leer el artículo completo en Yahoo Finance Inicie sesión para guardar

MediaNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (finance.yahoo.com)

Zealand Pharma announces positive topline results from the multiple ascending dose part of Phase 1 trial with Kv1.3 ion channel blocker ZP9830

También te puede interesar

Ukraine is making anti-Shahed missiles that have to cost less than $20,000 per shot

Zoom adds ‘proof of human’ badges to show you’re not a deepfake

Japanese Prime Minister Takaichi rejects criticism around weak yen and high interest rates

Oil Prices Slip as Trump-Putin Diesel Deal Raises Supply Hopes

Zcash developers plan a fix to keep ZEC swaps private from future quantum computers

China’s economy grew 4.5% last quarter, yet its export boom risks being ‘a drag on world growth’

Zealand Pharma announces positive topline results from the multiple ascending dose part of Phase 1 trial with Kv1.3 ion channel blocker ZP9830

Compartir

También te puede interesar

Ukraine is making anti-Shahed missiles that have to cost less than $20,000 per shot

Zoom adds ‘proof of human’ badges to show you’re not a deepfake

Japanese Prime Minister Takaichi rejects criticism around weak yen and high interest rates

Oil Prices Slip as Trump-Putin Diesel Deal Raises Supply Hopes

Zcash developers plan a fix to keep ZEC swaps private from future quantum computers

China’s economy grew 4.5% last quarter, yet its export boom risks being ‘a drag on world growth’